Member-only story
First AI-Generated Drug, FDA-Approved for Human Clinical Trials
The Frontier of AI in Medicine: The First FDA-Approved AI-Created Medication
In a historic milestone for both artificial intelligence and medicine, the FDA has approved the first drug fully generated by AI for clinical trials. This revolutionary step not only paves the way for future AI-created medications but also demonstrates the potential of AI to transform the pharmaceutical industry.
The AI Revolution in Drug Discovery
The drug, known as INS018_055, was developed by Insilico Medicine, a biotech startup that has been at the forefront of integrating AI into drug discovery¹. The medication is designed to treat idiopathic pulmonary fibrosis (IPF), a chronic and often fatal lung disease characterized by scarring of the lungs. With an increasing prevalence and limited treatment options, IPF represents a significant unmet medical need.
The Journey of INS018_055
The journey of INS018_055 began in 2020, with the ambitious goal of creating a "moonshot" medicine to address the…
